AI assistant
DEXCOM INC — Director's Dealing 2014
Mar 14, 2014
30198_dirs_2014-03-14_41957d54-e23d-4582-8856-5eed490f47f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-03-12
Reporting Person: SAYER KEVIN R (Director, President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-12 | Common Stock | D | 26421.0 | $45.2216 | Disposed | 453827 | Direct |
Footnotes
F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
F2: Included in this number are 308,231 unvested restricted stock units, 150,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 100,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 41,667 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 16,564 of which were granted on June 1, 2011 and shall vest through June 1, 2014.